These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3018244

  • 1. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors.
    Olsson RA, Kusachi S, Thompson RD, Ukena D, Padgett W, Daly JW.
    J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives.
    Cristalli G, Franchetti P, Grifantini M, Vittori S, Klotz KN, Lohse MJ.
    J Med Chem; 1988 Jun; 31(6):1179-83. PubMed ID: 3373486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow.
    Daly JW, Padgett W, Thompson RD, Kusachi S, Bugni WJ, Olsson RA.
    Biochem Pharmacol; 1986 Aug 01; 35(15):2467-81. PubMed ID: 3017353
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists.
    Baraldi PG, Cacciari B, Pineda de Las Infantas MJ, Romagnoli R, Spalluto G, Volpini R, Costanzi S, Vittori S, Cristalli G, Melman N, Park KS, Ji XD, Jacobson KA.
    J Med Chem; 1998 Aug 13; 41(17):3174-85. PubMed ID: 9703463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor.
    Trivedi BK, Bristol JA, Bruns RF, Haleen SJ, Steffen RP.
    J Med Chem; 1988 Jan 13; 31(1):271-3. PubMed ID: 3336027
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors.
    Ukena D, Shamim MT, Padgett W, Daly JW.
    Life Sci; 1986 Aug 25; 39(8):743-50. PubMed ID: 3016449
    [Abstract] [Full Text] [Related]

  • 19. Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor.
    van Galen PJ, Ijzerman AP, Soudijn W.
    FEBS Lett; 1987 Oct 19; 223(1):197-201. PubMed ID: 2959564
    [Abstract] [Full Text] [Related]

  • 20. Dog coronary artery adenosine receptor: structure of the N6-aryl subregion.
    Kusachi S, Thompson RD, Yamada N, Daly DT, Olsson RA.
    J Med Chem; 1986 Jun 19; 29(6):989-96. PubMed ID: 3012086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.